Experienced Health Economist with strong HTA and market access experience at both the UK and Global level. Work across a range of disease areas, including immunology, diabetes, oncology and virology. Focussed and organised, with extensive project management skills. In-depth knowledge of UK reimbursement pathways, as well as strong familiarity with international markets e.g. Canada, Germany, Republic of Ireland, France and Italy. Current responsibilities encompass strategic and technical support for global HTA deliverables, HTA submissions, cost-effectiveness and budget impact models and market access strategy, as well as mentoring of team members.

At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives.